Assignee
OPHIREX INC
US·3 granted patents·4 pending applications·2 citations·filing 2015–2024
Top patents by PatentIndex Score
7 records- 0179US12564575B2Early management, mitigation and prevention of sepsis and sepsis-like syndromes, including neo-natal ARDS due to infection, injury or iatrogenesisOPHIREX INC·Filed 2022·Granted Mar 3, 2026·1 cites·29 claims
- 0262US2025120949A1Use of spla2 inhibitors to treat envenomation by snakes and waspsOPHIREX INC·Filed 2024·Application pending·0 cites
- 0359US11000506B2Envenomation therapies and related pharmaceutical compositions, systems and kitsOPHIREX INC·Filed 2015·Granted May 11, 2021·1 cites·23 claims
- 0457US2025120950A1Use of spla2 inhibitors to treat hymenoptera envenomation, hemolysis, and kidney disease, and to protect blood from osmotic fragilityOPHIREX INC·Filed 2024·Application pending·0 cites
- 0550US2024382452A1Compositions and dosage forms for topical and transdermal delivery of actives and methods of useOPHIREX INC·Filed 2022·Application pending·0 cites
- 0642US12383531B2PLA2 inhibitors for treatment of pathological conditions caused by hymenoptera envenomation, such as hemolysis, cerebral edema, and acute kidney injuryOPHIREX INC·Filed 2017·Granted Aug 12, 2025·0 cites·14 claims
- 0742US2022370411A1EARLY MANAGEMENT, MITIGATION and PREVENTION OF SEPSIS and SEPSIS-LIKE SYNDROMES, INCLUDING NEO-NATAL ARDS DUE TO INFECTION, INJURY or IATROGENESISOPHIREX INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →